|
R&D Pipeline News Vol. 2, Issue 20: Wyeth, Dong-A & ViroMed Pipelines |
|
|
|
29 May 2006 |
Read the highlights of the most recent edition of our weekly R&D information product R&D Pipeline News. The Special Product or Technology Pipelines of R&D Pipeline News are available via subscription of R&D Pipeline News or as a single Project Pipeline List .
 |
| |
Special Company Pipelines:
|
Vol. 2 Issue nº 20
May 29, 2006
|
 |
|
|
Special Company Pipeline
|
R&D Pipeline Wyeth
|
- Advanced pipeline projects in traditional therapeutic areas of women's health, gastrointestinal, infectious diseases and psychiatry;
- New R&D focus on oncology;
- Increasing importance of biologics including proteins, peptides and antibodies;
- Traditional strength in vaccines;
- Several antibody-drug conjugates (ADC) with calicheamicin in oncology
|
Dong-A Pharmaceuticals (South Korea)
|
- Several biogeneric products on market;
- Natural products or extracts for inflammatory diseases;
- Gene therapy and DNA vaccine projects in clinical development
|
ViroMed (South Korea)
|
- Projects include proteins and gene therapy;
- Gene therapy with retroviral vector and proprietary naked plasmids;
- Two clinical stage projects in Asian countries;
- Therapeutic areas cardiovascular, infectious and oncology
|
|
R&D Pipeline News
Get your Subscription Now
|
R&D Pipeline News is a premier information source about research and development (R&D) projects in the pipeline of the biopharmaceutical industry and is directed to all stakeholders in R&D . R&D Pipeline News covers all relevant treatment modalities, including. drugs, medical devices, biomaterials, combination products, cell therapy and drug delivery products.
Read more about R&D Pipeline NewsOrder Now
 
|
|
|
|
|
|
|
|
|
